|
TTLL5 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.10782519111308E-15 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.36609999978887E-07 |
| Normal-vs-Stage2 |
5.75929999999669E-05 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
4.424700E-04 |
| Stage1-vs-Stage2 |
8.497600E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
3.741000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
4.311000E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.63404878306528E-12 |
| Normal-vs-AfricanAmerican |
9.882300E-02 |
| Normal-vs-Asian |
9.37660005195795E-09 |
| Caucasian-vs-AfricanAmerican |
5.009000E-01 |
| Caucasian-vs-Asian |
3.884200E-01 |
| AfricanAmerican-vs-Asian |
9.548400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04220000021849E-07 |
| Normal-vs-Female |
4.5511999724468E-09 |
| Male-vs-Female |
3.167800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.75440000000205E-05 |
| Normal-vs-Extreme_Weight |
9.9983999968245E-08 |
| Normal-vs-Obese |
1.78109999999787E-05 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
3.627200E-01 |
| Normal_Weight-vs-Obese |
1.321110E-03 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
2.22819999999846E-05 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.59489998774865E-09 |
| Normal-vs-Age(41-60Yrs) |
1.85976000000032E-05 |
| Normal-vs-Age(61-80Yrs) |
7.37729999311654E-09 |
| Normal-vs-Age(81-100Yrs) |
3.437400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.267600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.866200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.571630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.475000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.142200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.538400E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
5.156200E-01 |
| Normal-vs-Grade 3 |
6.612600E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
5.800000E-01 |
| Grade 2-vs-Grade 4 |
5.156200E-01 |
| Grade 3-vs-Grade 4 |
6.612600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.75530043225558E-10 |
| Normal-vs-N1 |
1.279260E-03 |
| N0-vs-N1 |
5.879800E-02 |
|
|
